News of European pancreatology (by materials of the 51st Meeting of the European Pancreatic Club)
PDF (Русский)
DOCX (Українська)


European Pancreatic Club, Ukrainian Pancreatic Club, progress of pancreatology, diagnostics and treatment of chronic pancreatitis, pancreatic insufficiency

How to Cite

Gubergrits, N. B., Byelyayeva, N. V., Lukashevich, G. M., Klochkov, A. Y., Fomenko, P. G., Yaroshenko, L. A., Yuryeva, A. V., & Rakhmetova, V. S. (2019). News of European pancreatology (by materials of the 51st Meeting of the European Pancreatic Club). Herald of Pancreatic Club, 45(4), 6-16.

Abstract views: 180
PDF Downloads: 106 PDF Downloads: 52 PDF Downloads: 61


This article presents an overview of the results of practical and basic research in the field of pancreatology, which were presented during the 51st Meeting of the European Pancreatic Club (2019). Achievements of leading European pancreatologists in the study of the etiology, pathogenesis, diagnosis, treatment of pancreatitis, pancreatic tumors are briefly described. The article presents clinical features of acute and chronic pancreatitis, depending on the variety of concomitant pathology, genetic characteristics, bad habits, drugs taken. New opportunities for the differential diagnosis of chronic pancreatitis and pancreatic cancer using miRNA are considered, as well as the feasibility of determining the soluble urokinase-type plasminogen activator receptor (suPAR) in order to differentiate benign and malignant pancreatic tumors. Approaches to the diagnosis of abdominal pain, use of computed tomography for the diagnosis of sarcopenia are described. Results of basic research analyzing the mechanisms of pancreatic cancer development are presented. Modern theory on the role of microbiota and syndrome of bacterial overgrowth in the pancreatic oncogenesis processes is revealed. Pathogenetic features of the formation of exocrine pancreatic insufficiency and effectiveness of its correction via enzyme replacement therapy with the use of modern drugs are emphasized. Results of randomized controlled studies that proved effectiveness and safety of microtablet preparation in correction of exocrine pancreatic insufficiency in patients undergoing pancreatoduodenectomy are presented.
PDF (Русский)
DOCX (Українська)


1. 51st European Pancreatic Club (EPC) meeting. Pancreatology. 2019. Vol. 19, No S1. P. S1–S180.
2. Akshintala V. S., Talukdar R., Singh V. K., Goggins M. The Gut Microbiome in Pancreatic Disease. Clinical Gastroenterology and Hepatology. 2019. Vol. 17, No 2. P. 290-295.
3. de la Iglesia-Garcia D, Vallejo-Senra N, Iglesias-Garcia J, López-López A, Nieto L, Domínguez-Muñoz JE. Increased Risk of Mortality Associated With Pancreatic Exocrine Insufficiency in Patients With Chronic Pancreatitis. J Clin Gastroenterol. 2018. Vol. 52, No 8. Е63-Е72.
4. Ramesh H, Reddy N, Bhatia S, Rajkumar JS, Bapaye A, Kini D, Kalla M, Thorat V. A 51-week, open-label clinical trial in India to assess the efficacy and safety of pancreatin 40000 enteric-coated minimicrospheres in patients with pancreatic exocrine insufficiency due to chronic pancreatitis. Pancreatology. 2013. Vol. 13, No 2. Р. 133-9.
5. Seiler CM, Izbicki J, Varga-Szabó L, Czakó L, Fiók J, Sperti C, Lerch MM, Pezzilli R, Vasileva G, Pap A, Varga M, Friess H. Randomised clinical trial: a 1-week, double-blind, placebo-controlled study of pancreatin 25 000 Ph. Eur. minimicrospheres (Creon 25000 MMS) for pancreatic exocrine insufficiency after pancreatic surgery, with a 1-year open-label extension. Aliment Pharmacol Ther. 2013. Vol. 37, No 7. Р. 691-702.
6. Thomas RM, Zajac-Kaye M. Microbial marauders: pancreatic microbiota and its impact on carcinogenesis. Ann Transl Med. 2018. Vol. 6, Suppl. 1. S63.
7. Wei M.-Y., Shi S., Liang C., Meng Q.-C., Hua J., Zhang Y.-Y., Liu J., Zhang B., Xu J., Yu X.-J. The microbiota and microbiome in pancreatic cancer: more influential than expected. Molecular Cancer. 2019. Vol. 18. Р. 97.